JP2002536413A - 末梢ニューロパシーの治療における4−アミノピリジンの使用 - Google Patents
末梢ニューロパシーの治療における4−アミノピリジンの使用Info
- Publication number
- JP2002536413A JP2002536413A JP2000598162A JP2000598162A JP2002536413A JP 2002536413 A JP2002536413 A JP 2002536413A JP 2000598162 A JP2000598162 A JP 2000598162A JP 2000598162 A JP2000598162 A JP 2000598162A JP 2002536413 A JP2002536413 A JP 2002536413A
- Authority
- JP
- Japan
- Prior art keywords
- aminopyridine
- nervous system
- peripheral nervous
- subject
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11927399P | 1999-02-09 | 1999-02-09 | |
| US60/119,273 | 1999-02-09 | ||
| PCT/US2000/003396 WO2000047210A1 (en) | 1999-02-09 | 2000-02-09 | Use of 4-amino pyridine for treatment of peripheral neuropathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002536413A true JP2002536413A (ja) | 2002-10-29 |
| JP2002536413A5 JP2002536413A5 (cg-RX-API-DMAC7.html) | 2007-04-05 |
Family
ID=22383494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000598162A Pending JP2002536413A (ja) | 1999-02-09 | 2000-02-09 | 末梢ニューロパシーの治療における4−アミノピリジンの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6503931B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1152760B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002536413A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE357914T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU3360000A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2360326C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60034110T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1152760T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2284485T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000047210A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2820423B1 (fr) * | 2001-02-05 | 2005-12-02 | Assist Publ Hopitaux De Paris | Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations |
| US20050192321A1 (en) * | 2003-09-15 | 2005-09-01 | Meythaler Jay M. | Treatment of neuropathy with rapid release aminopyridine |
| US10793893B2 (en) | 2011-06-30 | 2020-10-06 | Serb Sa | Methods of administering 3,4-diaminopyridine |
| TWI592156B (zh) * | 2011-10-04 | 2017-07-21 | 艾可達醫療公司 | 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法 |
| US9993429B2 (en) | 2013-03-15 | 2018-06-12 | University Of Rochester | Composition and methods for the treatment of peripheral nerve injury |
| MA35698B1 (fr) * | 2013-05-16 | 2014-12-01 | Univ Mohammed V Souissi | Nouvelle composition du 3,4-diaminopyridin pour le traitement de la fatigabilité musculaire associée à des troubles neurovégétatifs. |
| WO2024011220A1 (en) | 2022-07-08 | 2024-01-11 | University Of Rochester | Potassium channel blockers or derivatives thereof for preventing, alleviating, and/or treating tissue dysfunction caused by toxic insults |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5221683A (en) * | 1984-03-19 | 1993-06-22 | The Rockefeller University | Diaminopyridine compounds and methods of use |
| US4855290A (en) * | 1985-05-10 | 1989-08-08 | State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research | Derivatives of quinuclidine |
| IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| CA2085785C (en) * | 1992-12-18 | 2005-03-15 | Robert R. Hansebout | The use of 4-aminopyridine in the treatment of a neurological condition |
-
2000
- 2000-02-09 EP EP00911753A patent/EP1152760B1/en not_active Expired - Lifetime
- 2000-02-09 DK DK00911753T patent/DK1152760T3/da active
- 2000-02-09 US US09/913,082 patent/US6503931B1/en not_active Expired - Lifetime
- 2000-02-09 WO PCT/US2000/003396 patent/WO2000047210A1/en not_active Ceased
- 2000-02-09 DE DE60034110T patent/DE60034110T2/de not_active Expired - Lifetime
- 2000-02-09 ES ES00911753T patent/ES2284485T3/es not_active Expired - Lifetime
- 2000-02-09 CA CA2360326A patent/CA2360326C/en not_active Expired - Lifetime
- 2000-02-09 AT AT00911753T patent/ATE357914T1/de not_active IP Right Cessation
- 2000-02-09 AU AU33600/00A patent/AU3360000A/en not_active Abandoned
- 2000-02-09 JP JP2000598162A patent/JP2002536413A/ja active Pending
Non-Patent Citations (3)
| Title |
|---|
| CSNC200900212021, 馬場 正之, "Lewis—Sumner症候群", 医学のあゆみ IGAKU NO AYUMI, 第154巻, 三浦 裕士 医歯薬出版株式会社 * |
| CSNC200900542017, 結城 伸泰 Nobuhiro YUUKI, "変貌を遂げたGuillain−Barre症候群の疾患概念 Changing concept of Guillain−Barre syndrom", 医学のあゆみ IGAKU NO AYUMI, 第181巻, 三浦 裕士 医歯薬出版株式会社 * |
| CSNC200900625071, 堀田 饒 Nigishi HOTTA, "糖尿病性神経障害の病態と治療 Pathophysiology and treatment of diabetic neuropathy", 医学のあゆみ IGAKU NO AYUMI, 第188巻, 三浦 裕士 医歯薬出版株式会社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1152760B1 (en) | 2007-03-28 |
| DK1152760T3 (da) | 2007-07-30 |
| EP1152760A4 (en) | 2005-03-23 |
| DE60034110D1 (de) | 2007-05-10 |
| WO2000047210A1 (en) | 2000-08-17 |
| ATE357914T1 (de) | 2007-04-15 |
| ES2284485T3 (es) | 2007-11-16 |
| US6503931B1 (en) | 2003-01-07 |
| CA2360326C (en) | 2011-04-05 |
| CA2360326A1 (en) | 2000-08-17 |
| AU3360000A (en) | 2000-08-29 |
| DE60034110T2 (de) | 2007-12-06 |
| EP1152760A1 (en) | 2001-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Murray et al. | Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission | |
| US6518259B1 (en) | Compositions for treating autoimmune disease | |
| Graybill et al. | Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients | |
| JP2001513552A (ja) | 線維筋痛及び慢性疲労症候群の治療における酪酸塩誘導体 | |
| US6432937B1 (en) | Treatment for joint inflammation | |
| Byers et al. | Steroid myopathy: report of five cases occurring during treatment of rheumatic fever | |
| Kostadinova et al. | 4-aminopyridine–the new old drug for the treatment of neurodegenerative diseases | |
| JP2026505367A (ja) | 高タンパク尿慢性腎疾患の治療のためのジボテンタン及びダパグリフロジンの合剤 | |
| CA2360326C (en) | Use of 4-amino pyridine for treatment of peripheral neuropathies | |
| WO2019171333A1 (en) | Treatment of demyelinating diseases | |
| Abraham et al. | Colchicine therapy for low‐dose‐methotrexate‐induced accelerated nodulosis in a rheumatoid arthritis patient | |
| JP7794807B2 (ja) | 気道疾患の治療に使用するための(1r,3s)-3-((5-シアノ-4-フェニルチアゾール-2-イル)カルバモイル)シクロペンタン-1-カルボン酸およびその誘導体 | |
| Bradley et al. | Double‐blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia | |
| CN116033900A (zh) | 治疗冠状病毒暴露所致疾病的方法 | |
| JP2002530327A (ja) | 硝酸ミコナゾールによる陰門膣カンジダ症を治療するための方法および装置 | |
| JP7621668B2 (ja) | 疾患の処置用の2-(ジエチルアミノ)エチル2-(4-イソブチルフェニル)プロピオネートの局所投与 | |
| WO2019171332A1 (en) | Treatment of demyelinating diseases | |
| US20250161255A1 (en) | New therapy and prevention for suppressing aging-related disorders including sarcopenia | |
| US20050059709A1 (en) | Treatment of a neuropathy with rapid release aminopyridine | |
| TW202502329A (zh) | 用於治療脊髓性肌萎縮的組成物及方法 | |
| Herrmann Jr | Myasthenia gravis: brief guide to diagnosis and management | |
| US20050192321A1 (en) | Treatment of neuropathy with rapid release aminopyridine | |
| TW202438060A (zh) | 用於治療夏柯-馬利-杜斯氏症的組成物及方法 | |
| JP2003518045A (ja) | 小児患者におけるアレルギー性状態および炎症性状態の処置のためのデスロラタジンの使用 | |
| D ITOP | DITOPHAL IN THE TREATMENT OF LEPROSY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070208 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070208 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100617 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100917 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100928 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110303 |